TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Juno Therapeutics Inc (NASDAQ:JUNO) Investor Investigation Over Potential Breaches Of Fiduciary Duties Announced

  • If you purchased shares of Juno Therapeutics Inc (NASDAQ:JUNO), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Juno Therapeutics Inc
Security
NASDAQ: JUNO

Summary

March 21, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Juno Therapeutics Inc (NASDAQ:JUNO) was announced over potential breaches of fiduciary duties by certain officers and directors at Juno Therapeutics.

The investigation by a law firm concerns whether certain Juno Therapeutics Inc directors breached their fiduciary duties.

Juno Therapeutics Inc reported that its Net Loss increased from $243.41 million in 2014 to $239.38 million in 2015.

Shares of Juno Therapeutics Inc (NASDAQ:JUNO) declined from $68.36 per share in June 2015 to as low as $22.37 per share on February 3, 2016.

Start Monitoring Your Investments